← Database
Anxiolytic Peptide

Selank

Third-party suppliers · research use only · not an endorsement. Some links are affiliate links — purchases made through them may earn this site a commission.
Overview

Studied clinically in Russia for generalized anxiety; not FDA/EMA approved, with limited Western trial data.

How it works

Selank is a synthetic peptide based on tuftsin, a naturally occurring immune-signaling fragment, and was also developed in Russia, primarily as an anti-anxiety agent.

Its proposed calming effect is attributed to several actions: modulating GABA signaling (the brain's main 'brake'), slowing the breakdown of the body's own calming peptides (enkephalins), and influencing BDNF — together producing anxiolytic effects without the dependence typical of sedatives.

As with Semax, the supporting evidence comes largely from a Russian clinical tradition and is limited by Western standards; it is not an approved medication.

Mechanism · Detailed Analysis
Molecular targetA synthetic analogue of the immunopeptide tuftsin.
Proposed downstream effectsProposed GABAergic modulation, stabilisation of enkephalins (slowing their degradation), and BDNF effects — an anxiolytic profile without classic sedative dependence.
Evidence & caveatsAnxiolytic claims rest on a largely Russian clinical tradition with limited Western data. Not approved.
Published EvidenceLoading cited studies from PubMed…
Human Data ···

Searching the published record…

Animal ···

Searching the published record…

In Vitro ···

Searching the published record…

Educational aggregation of public literature. Not medical advice and not a recommendation to use any compound. Many compounds here are not approved for human use. Consult a licensed clinician.